Global Business Innovation Programme in Sweden - Advanced Therapies

Innovate UK is inviting ambitious companies developing Advanced Therapy Medicinal Products (ATMP) to participate in the Global Business Innovation Programme with a market visit to Sweden.

Opportunity Details

When

Registration Opens

16/08/2023

Registration Closes

22/09/2023

Award

Innovate UK will fund and organise return flights, accommodation, and in-market group travel for successful applicants and one night's overnight accommodation and dinner for the pre-visit workshop. Innovate UK will also pay for any reasonable adjustments throughout the initiative. Only one representative from each company will be funded. You will also receive follow-on support from an Innovate UK EDGE innovation & growth specialist.

Organisation

Innovate UK

Share this opportunity

Note: This opportunity is fully funded support and not monetary funding.

The Global Business Innovation Programme (GBIP), organised by Innovate UK and delivered by Innovate UK EDGE, consists of a preparation phase, a 5-day innovation visit, a post-visit exploitation workshop and support from an Innovate UK EDGE innovation & growth specialist, helping your business maximise the opportunities identified, including developing innovation projects with partners in the territory. This initiative will be delivered physically and could include virtual activities.

This programme is particularly relevant to companies working on innovative and sustainable biomanufacturing processes and process technologies that enable the development of ATMP and delivery systems, including but not limited to:

  • Manufacturing of cell therapies such as stem cell, natural killer (NK) cells, Tcell, and other engineered cell therapies
  • Manufacturing of gene therapies using viral, and non-viral vectors
  • mRNA and viral vector-based vaccine manufacturing
  • Manufacturing of regenerative medicine
  • Development of personalised medicines

Find out how our GBIP in Sweden can help your business grow.

  • A GBIP has three stages:

    Prepare for the market

    Preparing for the market includes the cohort being briefed by sector and market experts on, for example, cultural aspects of conducting business in that country. Delegates receive help to find business partners and arrange meetings and are advised on best practice including the management and protection of their intellectual property.

    Visiting the market

    Visiting the market provides opportunities to attend pre-arranged meetings and activities in order to better understand and maximise the opportunities that the visit presents.

    Exploiting the opportunity

    Exploiting the opportunity is arguably the most important aspect of the programme. To maximise the opportunity, participating companies are given bespoke one-to-one support from an Innovate UK EDGE innovation and growth specialist to help develop and implement an action plan.

    The Global Business Innovation Programme operates on a competitive basis and businesses selected are required to participate in all three stages (some or all of which may be online).

  • To apply, you must:

    • Be a UK-based innovation-led company with ambitions to grow and expand overseas.
    • Be a company with fewer than 500 employees.
    • Be able to attend and complete all activities.
  • Sweden is one of the most innovative countries in the world and a global leader in the health and life sciences sector.  With ambitions to be a world leader in ATMP development by 2030, the country benefits from a thriving biotechnology network and national initiatives coordinated by ATMP Sweden. In May 2023 the Swedish government, through Vinnova, the Swedish Innovation Agency, announced a 160 million SEK budget to establish several national clusters for the commercialisation of advanced therapies, such as the Centre for Commercialisation of Regenerative Medicine, CCRM Nordic, which will be located in “GoCo”, Gothenburg’s Health Innovation City. In 2022, the UK and Sweden signed a joint Memorandum of Understanding on health and life sciences, highlighting ATMP as a priority.  The UK and Swedish governments are due to sign a Strategic Partnership Agreement by the end of this year, which also highlights this important sector.  Opportunities for UK-Swedish ATMP collaboration and partnerships are therefore timely and significant.

  • This programme is particularly relevant to companies working on innovative and sustainable biomanufacturing processes and process technologies that enable the development of ATMP and delivery systems, including but not limited to:

    • Manufacturing of cell therapies such as stem cell, natural killer (NK) cells, Tcell, and other engineered cell therapies
    • Manufacturing of gene therapies using viral, and non-viral vectors
    • mRNA and viral vector-based vaccine manufacturing
    • Manufacturing of regenerative medicine
    • Development of personalised medicines
  • Innovate UK and Innovate UK EDGE will fund and organise flights, accommodation, and any conference fees for successful applicants. Innovate UK will also pay for any reasonable adjustments throughout the initiative. Only one representative from each company will be funded.

    On acceptance, a commitment fee of £500 will be obtained from each delegate, which will be refunded on completion of the full activities and agreed action plan. Non-completion after formal acceptance may result in forfeiting some or all the commitment fees.

  • Register for the applicant briefing event on 30th August from 9am-10am

    Closing date for application: 22nd September 2023 at 5pm
    Two-day pre-visit workshop: 19th – 20th October 2023
    Innovation visit: 21st – 26th January 2024
    Exploitation workshop: 12th March 2024

    For more information, assistance with your application or to discuss accessibility needs, please email sarah.hildersley@innovateukedge.ukri.org or call 07435 008825.

Close

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.